The Relationship of Frequency of Cocaine Use to Substance and Psychiatric Disorders in the U.S. General Population

Overview

Journal Drug Alcohol Depend

Publisher Elsevier

Specialty Psychiatry

Date 2021 Aug 6

PMID 34358768

Citations 3

Authors

Efrat Aharonovich

Jennifer Scodes

Melanie M Wall

Deborah S Hasin

Affiliations

Soon will be listed here.

Abstract

Background: In clinical trials of pharmacotherapy for substance use, abstinence is the primary endpoint accepted by regulatory agencies. However, this endpoint could be overly restrictive, impeding efforts to identify effective medications for cocaine use disorder. To examine non-abstinent gradations in cocaine use as potential indicators of improvement, we investigated the relationship of frequency of cocaine use to clinical correlates in national survey data.

Methods: Lifetime cocaine users (n = 2501) were interviewed in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC) in 2001-2002 and re-interviewed in 2004-2005. Adjusted odds ratios (aORs) indicated associations between heaviest frequency of cocaine use and use of other substances, DSM-IV substance use disorders, psychiatric disorders, and change between 2001-2002 and 2004-2005. The reference category for all aORs was non-users.

Results: Greater lifetime cocaine use frequency was associated with lifetime cocaine, alcohol, and cannabis dependence (aOR for a linear trend = 2.80, 1.22, 1.22, respectively) and past-year cocaine, alcohol, and cannabis dependence (aOR = 1.78, 1.13, 1.16, respectively). Greater lifetime cocaine use frequency was associated with past-year depressive, panic, and generalized anxiety disorders (aOR = 1.07, 1.09, 1.12, respectively). Among cocaine users in 2001-2002, compared to the reference group using less than monthly, use ≥1x/week and use 1-3 times a month was associated with cocaine use disorder in 2004-2005 (aOR = 2.13 and aOR = 1.67, respectively).

Conclusion: Gradations in risk for dependence on cocaine, other substances and psychiatric disorders by frequency of cocaine use indicates a promising direction for more sensitive outcome measures of treatment effects on cocaine outcomes than binary indicators (e.g., any use vs. none). Study results add to findings suggesting that non-abstinent measures might be useful indicators of treatment efficacy in clinical trials.

Citing Articles

Role of estrogen in sex differences in memory, emotion and neuropsychiatric disorders.

Iqbal J, Huang G, Xue Y, Yang M, Jia X Mol Biol Rep. 2024; 51(1):415.

PMID: 38472517 DOI: 10.1007/s11033-024-09374-z.

Polysubstance addiction patterns among 7,989 individuals with cocaine use disorder.

Stiltner B, Pietrzak R, Tylee D, Nunez Y, Adhikari K, Kranzler H iScience. 2023; 26(8):107336.

PMID: 37554454 PMC: 10405253. DOI: 10.1016/j.isci.2023.107336.

The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review.

Sepulveda Ramos C, Thornburg M, Long K, Sharma K, Roth J, Lacatusu D Cureus. 2022; 14(3):e23647.

PMID: 35505747 PMC: 9053551. DOI: 10.7759/cureus.23647.

References

Araos P, Vergara-Moragues E, Pedraz M, Pavon F, Campos Cloute R, Calado M . [Psychopathological comorbidity in cocaine users in outpatient treatment]. Adicciones. 2014; 26(1):15-26. View

Ruan W, Goldstein R, Chou S, Smith S, Saha T, Pickering R . The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend. 2007; 92(1-3):27-36. PMC: 2246381. DOI: 10.1016/j.drugalcdep.2007.06.001. View

Witkiewitz K, Hallgren K, Kranzler H, Mann K, Hasin D, Falk D . Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels. Alcohol Clin Exp Res. 2016; 41(1):179-186. PMC: 5205540. DOI: 10.1111/acer.13272. View

ODonnell J, Gladden R, Mattson C, Hunter C, Davis N . Vital Signs: Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants - 24 States and the District of Columbia, January-June 2019. MMWR Morb Mortal Wkly Rep. 2020; 69(35):1189-1197. PMC: 7470457. DOI: 10.15585/mmwr.mm6935a1. View

Kim S, Park T . Acute and Chronic Effects of Cocaine on Cardiovascular Health. Int J Mol Sci. 2019; 20(3). PMC: 6387265. DOI: 10.3390/ijms20030584. View

Hasin D, Stinson F, Ogburn E, Grant B . Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007; 64(7):830-42. DOI: 10.1001/archpsyc.64.7.830. View

Santurtun A, Garcia Blanco A, Fdez-Arroyabe P, Santurtun M, Zarrabeitia M . Cocaine in Hospital Admissions for Diseases of the Circulatory System and as the Underlying Cause of Death: Analysis and Discussion. Cardiovasc Toxicol. 2019; 20(1):20-27. DOI: 10.1007/s12012-019-09537-6. View

Nolan M, Shamasunder S, Colon-Berezin C, Kunins H, Paone D . Increased Presence of Fentanyl in Cocaine-Involved Fatal Overdoses: Implications for Prevention. J Urban Health. 2019; 96(1):49-54. PMC: 6391300. DOI: 10.1007/s11524-018-00343-z. View

Blanco C, Campbell A, Wall M, Olfson M, Wang S, Nunes E . Toward National Estimates of Effectiveness of Treatment for Substance Use. J Clin Psychiatry. 2017; 78(1):e64-e70. PMC: 5490656. DOI: 10.4088/JCP.15m10333. View

10.

Hasin D, Wall M, Witkiewitz K, Kranzler H, Falk D, Litten R . Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population. Lancet Psychiatry. 2017; 4(6):469-476. PMC: 5536861. DOI: 10.1016/S2215-0366(17)30130-X. View

11.

Witkiewitz K, Falk D, Litten R, Hasin D, Kranzler H, Mann K . Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial. Alcohol Clin Exp Res. 2019; 43(5):979-987. PMC: 6502682. DOI: 10.1111/acer.14018. View

12.

Jones C, Baldwin G, Compton W . Recent Increases in Cocaine-Related Overdose Deaths and the Role of Opioids. Am J Public Health. 2017; 107(3):430-432. PMC: 5296707. DOI: 10.2105/AJPH.2016.303627. View

13.

Grant B, Dawson D, Stinson F, Chou P, Kay W, Pickering R . The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003; 71(1):7-16. DOI: 10.1016/s0376-8716(03)00070-x. View

14.

Grant B, Harford T, Dawson D, CHOU P, Pickering R . The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995; 39(1):37-44. DOI: 10.1016/0376-8716(95)01134-k. View

15.

Knox J, Wall M, Witkiewitz K, Kranzler H, Falk D, Litten R . Reduction in non-abstinent World Health Organization (WHO) drinking risk levels and drug use disorders: 3-year follow-up results in the US general population. Drug Alcohol Depend. 2019; 201:16-22. PMC: 6662197. DOI: 10.1016/j.drugalcdep.2019.03.020. View

16.

Compton W, Thomas Y, Stinson F, Grant B . Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007; 64(5):566-76. DOI: 10.1001/archpsyc.64.5.566. View

17.

Kariisa M, Scholl L, Wilson N, Seth P, Hoots B . Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017. MMWR Morb Mortal Wkly Rep. 2019; 68(17):388-395. PMC: 6541315. DOI: 10.15585/mmwr.mm6817a3. View

18.

Zhornitsky S, Le T, Dhingra I, Adkinson B, Potvin S, Li C . Interpersonal Risk Factors for Suicide in Cocaine Dependence: Association with Self-Esteem, Personality Traits, and Childhood Abuse. Suicide Life Threat Behav. 2020; 50(4):867-883. PMC: 7518050. DOI: 10.1111/sltb.12621. View

19.

Martinez-Gras I, Ferre Navarrete F, Pascual Arriazu J, Penas Pascual J, de Iceta Ruiz de Gauna M, Fraguas Herraez D . Psychiatric comorbidity in a sample of cocaine-dependent outpatients seen in the Community of Madrid drug addiction care network. Adicciones. 2016; 28(1):6-18. DOI: 10.20882/adicciones.785. View

20.

Grant B, Goldstein R, Chou S, Huang B, Stinson F, Dawson D . Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2008; 14(11):1051-66. PMC: 2766434. DOI: 10.1038/mp.2008.41. View